Argatroban contraindications: Difference between revisions

Revision as of 01:58, 4 March 2014

Argatroban
Argatroban^® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Jesus Rosario Hernandez, M.D. [2]

Argatroban is contraindicated in:

Patients with major bleeding
Patients with a history of hypersensitivity to argatroban. Airway, skin, and generalized hypersensitivity reactions have been reported [see Adverse Reactions (6.4)]. ^[1]

Adapted from the FDA Package Insert.

@@ Line 5: / Line 5: @@
 ==Contraindications==
-Argatroban Injection is supplied in a single use vial containing 50 mg argatroban in 50 mL aqueous solution (1 mg/mL). The solution is ready for intravenous infusion. <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ARGATROBAN INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595 | publisher =  | date =  | accessdate = }}</ref>
+Argatroban is contraindicated in:
+* Patients with major bleeding
+* Patients with a history of hypersensitivity to argatroban. Airway, skin, and generalized hypersensitivity reactions have been reported [see Adverse Reactions (6.4)]. <ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = ARGATROBAN INJECTION, SOLUTION [GLAXOSMITHKLINE LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9c9616c0-a299-4fd5-c8ae-79e6db453595 | publisher =  | date =  | accessdate = }}</ref>
 ==Reference==